The Danish Medicines Agency has received the Reimbursement Committee's final recommendation for a revision pertaining to the reimbursement scheme for insulin products – and it doesn't bode well for Novo Nordisk.
Attempts to convince the committee to change their minds have fallen short. At the beginning of November, the Danish pharmaceutical firm objected to the change to reimbursements, which would see Novo Nordisk's fast-acting insulin Fiasp receive conditional reimbursement as opposed to a general reimbursement.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
"Real world" patient data documents the long-term effects of ALK vaccines
In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.
Y-mabs CEO has big ambitions: Wants to create the Tesla of biotech
CEO at Y-mabs Claus Møller sees the potential to create "the Tesla within biotechnology" in the Danish-American cancer company, as reported by Danish media Børsen.
Contact with consumers will secure continued growth in China, says Sonova
Hearing aid manufacturer Sonova says direct contact with consumers on the growing Chinese market will be the way forward to increase growth.
AGC's Japanese and Danish factories to produce German biotech firm's drug candidate
German 4teen4 has chosen AGC Biologics as contract developer for the clinical testing of its drug candidate, procizumab.
EMA begins rolling review of another Covid-19 vaccine
The European Medicines Agency will assess the potential vaccine being developed by Valneva as data trickles in.
GxP QA Compliance Manager for Quality Assurance 
Global Stakeholder Partnership Manager 
Senior Clinical Project Manager 
Clinical Trial Manager 
Senior Manager/Associate Director Regulatory Affairs 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Senior Clinical Trial Manager 
Area Sales Manager, Life Sciences, BU Øresund Region 
Medical Director 
Senior Manager, Global Regulatory Affairs CMC 
Procurement Manager 
Clinical Bioinformatician 
Join us! And start to impact healthcare through innovation 
Regulatory Science Specialist